$MDXG
MIMEDX GROUP, INC. Stock $mdxg

$mdxg Overview Financials Valuation SEC Filings Company Website

2022 Q3 Form 10-Q Financial Statement

#000137633922000099 Filed on August 02, 2022

Income Statement

Concept	2022 Q3	2022 Q2	2022 Q1
Revenue	$67.69M	$66.88M	$58.89M
YoY Change	7.32%	-1.88%	-1.79%
Cost Of Revenue	$12.19M	$11.82M	$9.936M
YoY Change	20.33%	-7.34%	3.06%
Gross Profit	$55.50M	$55.06M	$48.96M
YoY Change	4.83%	-0.62%	-2.72%
Gross Profit Margin	81.99%	82.32%	83.13%
Selling, General & Admin	$53.48M	$55.79M	$49.57M
YoY Change	15.52%	4.09%	9.18%
% of Gross Profit	96.35%	101.33%	101.25%
Research & Development	$5.953M	$5.512M	$5.964M
YoY Change	36.29%	35.66%	37.45%
% of Gross Profit	10.73%	10.01%	12.18%
Depreciation & Amortization	$831.0K	$858.0K	$860.0K
YoY Change	-9.97%	-34.3%	-25.93%
% of Gross Profit	1.5%	1.56%	1.76%
Operating Expenses	$59.43M	$61.31M	$55.53M
YoY Change	17.31%	6.32%	11.64%
Operating Profit	-$7.103M	-$9.636M	-$9.300M
YoY Change	560.74%	2250.24%	35.73%
Interest Expense	-$1.270M	-$1.170M	-$1.126M
YoY Change	31.88%	-14.66%	-23.4%
% of Operating Profit
Other Income/Expense, Net	$0.00	$0.00	$0.00
YoY Change		-100.0%
Pretax Income	-$8.373M	-$10.81M	-$10.43M
YoY Change	310.84%	505.72%	25.25%
Income Tax	$53.00K	$62.00K	$63.00K
% Of Pretax Income
Net Earnings	-$8.426M	-$10.87M	-$10.49M
YoY Change	260.24%	510.91%	25.14%
Net Earnings / Revenue	-12.45%	-16.25%	-17.81%
Basic Earnings Per Share	-$0.09	-$0.11	-$0.11
Diluted Earnings Per Share	-$0.09	-$0.11	-$0.11
COMMON SHARES
Basic Shares Outstanding	113.6M shares	112.9M shares	111.6M shares
Diluted Shares Outstanding	113.4M shares	112.9M shares	111.6M shares

Balance Sheet

Concept	2022 Q3	2022 Q2	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$73.22M	$72.50M	$75.68M
YoY Change	-19.19%	-14.71%	-10.65%
Cash & Equivalents	$73.22M	$72.50M	$75.68M
Short-Term Investments
Other Short-Term Assets	$2.582M	$2.570M	$2.571M
YoY Change	200.23%	41.52%	-27.17%
Inventory	$13.98M	$13.38M	$13.17M
Prepaid Expenses	$4.679M	$4.085M	$6.136M
Receivables	$40.83M	$37.66M	$37.67M
Other Receivables	$756.0K	$809.0K	$680.0K
Total Short-Term Assets	$136.0M	$131.0M	$135.9M
YoY Change	-4.13%	-11.3%	-9.37%
LONG-TERM ASSETS
Property, Plant & Equipment	$11.64M	$12.38M	$13.12M
YoY Change	-8.74%	-7.75%	18.82%
Goodwill	$19.98M	$19.98M	$19.98M
YoY Change	0.0%	0.0%	0.0%
Intangibles	$4.992M	$5.141M	$5.265M
YoY Change	-11.17%	-10.59%	-11.03%
Long-Term Investments
YoY Change
Other Assets	$150.0K	$164.0K	$172.0K
YoY Change	-44.44%	-47.6%	-50.0%
Total Long-Term Assets	$36.76M	$37.66M	$38.54M
YoY Change	-4.82%	-4.56%	-5.66%
TOTAL ASSETS
Total Short-Term Assets	$136.0M	$131.0M	$135.9M
Total Long-Term Assets	$36.76M	$37.66M	$38.54M
Total Assets	$172.8M	$168.7M	$174.4M
YoY Change	-4.28%	-9.87%	-8.58%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$8.820M	$8.075M	$8.120M
YoY Change	28.18%	-23.55%	17.26%
Accrued Expenses	$10.99M	$10.00M	$9.812M
YoY Change	-19.76%	-41.42%	-68.01%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$45.86M	$37.14M	$36.59M
YoY Change	9.85%	-26.56%	-33.96%
LONG-TERM LIABILITIES
Long-Term Debt	$48.48M	$48.36M	$48.24M
YoY Change	0.96%	0.94%	0.92%
Other Long-Term Liabilities	$5.491M	$4.282M	$4.553M
YoY Change	34.72%	29.21%	25.63%
Total Long-Term Liabilities	$53.97M	$52.64M	$52.79M
YoY Change	3.6%	2.77%	2.66%
TOTAL LIABILITIES
Total Short-Term Liabilities	$45.86M	$37.14M	$36.59M
Total Long-Term Liabilities	$53.97M	$52.64M	$52.79M
Total Liabilities	$99.82M	$89.78M	$89.38M
YoY Change	6.38%	-11.8%	-16.33%
SHAREHOLDERS EQUITY
Retained Earnings	-$191.5M	-$183.1M	-$172.2M
YoY Change	16.82%	13.29%	7.75%
Common Stock	$114.0K	$114.0K	$114.0K
YoY Change	0.88%	0.88%	0.88%
Preferred Stock
YoY Change
Treasury Stock (at cost)		$3.000K	$840.0K
YoY Change		-99.93%	-83.5%
Treasury Stock Shares		1.003K shares	172.8K shares
Shareholders Equity	-$19.52M	-$13.60M	-$7.434M
YoY Change
Total Liabilities & Shareholders Equity	$172.8M	$168.7M	$174.4M
YoY Change	-4.28%	-9.87%	-8.58%

Cashflow Statement

Concept	2022 Q3	2022 Q2	2022 Q1
OPERATING ACTIVITIES
Net Income	-$8.426M	-$10.87M	-$10.49M
YoY Change	260.24%	510.91%	25.14%
Depreciation, Depletion And Amortization	$831.0K	$858.0K	$860.0K
YoY Change	-9.97%	-34.3%	-25.93%
Cash From Operating Activities	$959.0K	-$3.005M	-$10.22M
YoY Change	-84.85%	-287.81%	53.06%
INVESTING ACTIVITIES
Capital Expenditures	-$374.0K	-$429.0K	$118.0K
YoY Change	-38.69%	-5.92%	-93.92%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$0.00	$24.00K
YoY Change	-100.0%	-100.0%	20.0%
Cash From Investing Activities	-$374.0K	-$429.0K	-$148.0K
YoY Change	-35.52%	1.9%	-92.88%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	130.0K	260.0K	-$1.036M
YoY Change	-186.67%	-128.45%	-55.11%
NET CHANGE
Cash From Operating Activities	959.0K	-3.005M	-$10.22M
Cash From Investing Activities	-374.0K	-429.0K	-$148.0K
Cash From Financing Activities	130.0K	260.0K	-$1.036M
Net Change In Cash	715.0K	-3.174M	-$11.41M
YoY Change	-87.23%	-1297.74%	3.08%
FREE CASH FLOW
Cash From Operating Activities	$959.0K	-$3.005M	-$10.22M
Capital Expenditures	-$374.0K	-$429.0K	$118.0K
Free Cash Flow	$1.333M	-$2.576M	-$10.34M
YoY Change	-80.79%	-225.29%	19.97%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Central Index Key EntityCentralIndexKey	0001376339
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-06-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-35887
	dei	Entity Registrant Name EntityRegistrantName	MIMEDX GROUP, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	FL
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	26-2792552
	dei	Entity Address Address Line1 EntityAddressAddressLine1	1775 West Oak Commons Ct NE
	dei	Entity Address City Or Town EntityAddressCityOrTown	Marietta
	dei	Entity Address State Or Province EntityAddressStateOrProvince	GA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	30062
	dei	City Area Code CityAreaCode	770
	dei	Local Phone Number LocalPhoneNumber	651-9100
	dei	Security12b Title Security12bTitle	Common Stock, par value $0.001 per share
	dei	Trading Symbol TradingSymbol	MDXG
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	false
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	113608607	shares
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	72502000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	87083000	usd
CY2022Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	37661000	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	40353000	usd
CY2022Q2	us-gaap	Inventory Net InventoryNet	13382000	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	11389000	usd
CY2022Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	4085000	usd
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	6146000	usd
CY2022Q2	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	809000	usd
CY2021Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	743000	usd
CY2022Q2	us-gaap	Other Assets Current OtherAssetsCurrent	2570000	usd
CY2021Q4	us-gaap	Other Assets Current OtherAssetsCurrent	2809000	usd
CY2022Q2	us-gaap	Assets Current AssetsCurrent	131009000	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	148523000	usd
CY2022Q2	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	8328000	usd
CY2021Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	9165000	usd
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	4049000	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	4696000	usd
CY2022Q2	us-gaap	Goodwill Goodwill	19976000	usd
CY2021Q4	us-gaap	Goodwill Goodwill	19976000	usd
CY2022Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	5141000	usd
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	5383000	usd
CY2022Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	164000	usd
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	186000	usd
CY2022Q2	us-gaap	Assets Assets	168667000	usd
CY2021Q4	us-gaap	Assets Assets	187929000	usd
CY2022Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	8075000	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	7385000	usd
CY2022Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	17280000	usd
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	23595000	usd
CY2022Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	10002000	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	9812000	usd
CY2022Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1781000	usd
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1565000	usd
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	37138000	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	42357000	usd
CY2022Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	48356000	usd
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	48127000	usd
CY2022Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	4282000	usd
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	4869000	usd
CY2022Q2	us-gaap	Liabilities Liabilities	89776000	usd
CY2021Q4	us-gaap	Liabilities Liabilities	95353000	usd
CY2022Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q2	us-gaap	Temporary Equity Par Or Stated Value Per Share TemporaryEquityParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Temporary Equity Par Or Stated Value Per Share TemporaryEquityParOrStatedValuePerShare	0.001
CY2022Q2	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	100000	shares
CY2021Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	100000	shares
CY2021Q4	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	100000	shares
CY2022Q2	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	100000	shares
CY2022Q2	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	100000	shares
CY2021Q4	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	100000	shares
CY2022Q2	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	92494000	usd
CY2021Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	92494000	usd
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	187500000	shares
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	187500000	shares
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	113609274	shares
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	113608271	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	112703926	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	111925216	shares
CY2022Q2	us-gaap	Common Stock Value CommonStockValue	114000	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	113000	usd
CY2022Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	169352000	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	165695000	usd
CY2022Q2	us-gaap	Treasury Stock Shares TreasuryStockShares	1003	shares
CY2021Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	778710	shares
CY2022Q2	us-gaap	Treasury Stock Value TreasuryStockValue	3000	usd
CY2021Q4	us-gaap	Treasury Stock Value TreasuryStockValue	4017000	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-183066000	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-161709000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	-13603000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	82000	usd
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	168667000	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	187929000	usd
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	66883000	usd
CY2021Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	68165000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	125777000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	128132000	usd
CY2022Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	11823000	usd
CY2021Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	12760000	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	21759000	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	22401000	usd
CY2022Q2	us-gaap	Gross Profit GrossProfit	55060000	usd
CY2021Q2	us-gaap	Gross Profit GrossProfit	55405000	usd
	us-gaap	Gross Profit GrossProfit	104018000	usd
	us-gaap	Gross Profit GrossProfit	105731000	usd
CY2022Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	55793000	usd
CY2021Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	53599000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	105363000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	99003000	usd
CY2022Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5512000	usd
CY2021Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4063000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	11476000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	8402000	usd
CY2022Q2	mdxg	Investigation Restatementand Related InvestigationRestatementandRelated	3218000	usd
CY2021Q2	mdxg	Investigation Restatementand Related InvestigationRestatementandRelated	-2062000	usd
	mdxg	Investigation Restatementand Related InvestigationRestatementandRelated	5770000	usd
	mdxg	Investigation Restatementand Related InvestigationRestatementandRelated	5134000	usd
CY2022Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	173000	usd
CY2021Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	215000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	345000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	454000	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-9636000	usd
CY2021Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-410000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-18936000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-7262000	usd
CY2022Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-1170000	usd
CY2021Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-1371000	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-2295000	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-2844000	usd
CY2022Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	0	usd
CY2021Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-3000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-2000	usd
CY2022Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-10806000	usd
CY2021Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1784000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-21232000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-10108000	usd
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	62000	usd
CY2021Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-5000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	125000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	53000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-10868000	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-1779000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-21357000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-10161000	usd
CY2022Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-12496000	usd
CY2021Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-3276000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-24571000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-13126000	usd
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.11
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.22
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.12
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.11
CY2021Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.03
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.22
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.12
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	112867912	shares
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	110276636	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	112245334	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	109841428	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	109841428	shares
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	112867912	shares
CY2021Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	110276636	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	112245334	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	109841428	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	109841428	shares
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	-7434000	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	4428000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	271000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	0	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures	0	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-10868000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	-13603000	usd
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	-8051000	usd
CY2021Q2	us-gaap	Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings	464000	usd
CY2021Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	4060000	usd
CY2021Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	444000	usd
CY2021Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	0	usd
CY2021Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures	0	usd
CY2021Q2	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	1347000	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-1779000	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	-7137000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	82000	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	8426000	usd
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	437000	usd
	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	0	usd
	us-gaap	Stock Issued During Period Value Restricted Stock Award Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures	0	usd
	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	1191000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-21357000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	-13603000	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-150000	usd
	us-gaap	Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings	926000	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	7304000	usd
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1359000	usd
	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	0	usd
	us-gaap	Stock Issued During Period Value Restricted Stock Award Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures	0	usd
	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	4563000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-10161000	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	-7137000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-21357000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-10161000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	8426000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	7304000	usd
	us-gaap	Depreciation Depreciation	1718000	usd
	us-gaap	Depreciation Depreciation	2467000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	2391000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	345000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	454000	usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	229000	usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	833000	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	610000	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	480000	usd
	us-gaap	Asset Retirement Obligation Accretion Expense AssetRetirementObligationAccretionExpense	46000	usd
	us-gaap	Asset Retirement Obligation Accretion Expense AssetRetirementObligationAccretionExpense	37000	usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	15000	usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-236000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-301000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1820000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1993000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-224000	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-2061000	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-2254000	usd
	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	66000	usd
	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	93000	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	287000	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-1387000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	442000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	2794000	usd
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-6316000	usd
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	2790000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	740000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-13752000	usd
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-503000	usd
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-514000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-13228000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-5080000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	498000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2346000	usd
	mdxg	Paymentsfor Application Costs Patent PaymentsforApplicationCostsPatent	103000	usd
	mdxg	Paymentsfor Application Costs Patent PaymentsforApplicationCostsPatent	200000	usd
	us-gaap	Proceeds From Collection Of Notes Receivable ProceedsFromCollectionOfNotesReceivable	0	usd
	us-gaap	Proceeds From Collection Of Notes Receivable ProceedsFromCollectionOfNotesReceivable	45000	usd
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	24000	usd
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	0	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-577000	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	4563000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	437000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2501000	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	1191000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1359000	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	22000	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	20000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-776000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-3224000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-14581000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-10805000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	87083000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	95812000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	72502000	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	85007000	usd
	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited condensed consolidated financial statements have been prepared in accordance with GAAP. Conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed consolidated financial statements and the reported unaudited condensed consolidated statements of operations during the reporting period. Actual results could differ from those estimates. Significant estimates include estimated useful lives and potential impairment of property and equipment and intangible assets, estimates regarding asset retirement obligations, estimates for contingent liabilities, the measurement of right of use assets and lease liabilities, management’s assessment of the Company’s ability to continue as a going concern, estimates of fair value of share-based payments, estimate for allowance for doubtful accounts, estimates of sales returns and allowances, and valuation of deferred tax assets.</span></div>
CY2022Q2	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	41132000	usd
CY2021Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	41540000	usd
CY2022Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	3471000	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1187000	usd
CY2022Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	37661000	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	40353000	usd
CY2022Q2	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	2200000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	2400000	usd
CY2022Q2	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	671000	usd
CY2021Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	364000	usd
CY2022Q2	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	7954000	usd
CY2021Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	6112000	usd
CY2022Q2	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	4757000	usd
CY2021Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	4913000	usd
CY2022Q2	us-gaap	Inventory Net InventoryNet	13382000	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	11389000	usd
CY2022Q2	us-gaap	Finance Lease Right Of Use Asset Before Accumulated Amortization FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization	189000	usd
CY2021Q4	us-gaap	Finance Lease Right Of Use Asset Before Accumulated Amortization FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization	189000	usd
CY2022Q2	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization	42628000	usd
CY2021Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization	42043000	usd
CY2022Q2	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization	34300000	usd
CY2021Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization	32878000	usd
CY2022Q2	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	8328000	usd
CY2021Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	9165000	usd
CY2022Q2	us-gaap	Depreciation Depreciation	858000	usd
CY2021Q2	us-gaap	Depreciation Depreciation	1306000	usd
	us-gaap	Depreciation Depreciation	1718000	usd
	us-gaap	Depreciation Depreciation	2467000	usd
CY2022Q2	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	11894000	usd
CY2022Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	5141000	usd
CY2021Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	11791000	usd
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	5383000	usd
CY2022Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	173000	usd
CY2021Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	215000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	345000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	454000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	348000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	696000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	696000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	301000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	147000	usd
CY2022Q2	mdxg	Finite Lived Intangible Asset Expected Amortization After Year Four FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour	849000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	3037000	usd
CY2022Q2	us-gaap	Accrued Professional Fees Current And Noncurrent AccruedProfessionalFeesCurrentAndNoncurrent	3202000	usd
CY2021Q4	us-gaap	Accrued Professional Fees Current And Noncurrent AccruedProfessionalFeesCurrentAndNoncurrent	2806000	usd
CY2022Q2	us-gaap	Accrued Sales Commission Current AccruedSalesCommissionCurrent	2086000	usd
CY2021Q4	us-gaap	Accrued Sales Commission Current AccruedSalesCommissionCurrent	2630000	usd
CY2022Q2	mdxg	Accrued Administrative Fees Current AccruedAdministrativeFeesCurrent	1099000	usd
CY2021Q4	mdxg	Accrued Administrative Fees Current AccruedAdministrativeFeesCurrent	559000	usd
CY2022Q2	us-gaap	Contract With Customer Refund Liability Current ContractWithCustomerRefundLiabilityCurrent	672000	usd
CY2021Q4	us-gaap	Contract With Customer Refund Liability Current ContractWithCustomerRefundLiabilityCurrent	788000	usd
CY2022Q2	mdxg	Accrued Travel AccruedTravel	611000	usd
CY2021Q4	mdxg	Accrued Travel AccruedTravel	385000	usd
CY2022Q2	mdxg	Accrued Clinical Trials Current AccruedClinicalTrialsCurrent	611000	usd
CY2021Q4	mdxg	Accrued Clinical Trials Current AccruedClinicalTrialsCurrent	694000	usd
CY2022Q2	mdxg	Accrued Rebates AccruedRebates	551000	usd
CY2021Q4	mdxg	Accrued Rebates AccruedRebates	1343000	usd
CY2022Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1170000	usd
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	607000	usd
CY2022Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	10002000	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	9812000	usd
CY2022Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	0	usd
CY2022Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	0	usd
CY2022Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	0	usd
CY2022Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	50000000	usd
CY2022Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	0	usd
CY2022Q2	mdxg	Long Term Debt Maturity After Year Four LongTermDebtMaturityAfterYearFour	0	usd
CY2022Q2	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	50000000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-10868000	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-1779000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-21357000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-10161000	usd
CY2022Q2	us-gaap	Temporary Equity Dividends Adjustment TemporaryEquityDividendsAdjustment	1628000	usd
CY2021Q2	us-gaap	Temporary Equity Dividends Adjustment TemporaryEquityDividendsAdjustment	1033000	usd
	us-gaap	Temporary Equity Dividends Adjustment TemporaryEquityDividendsAdjustment	3214000	usd
	us-gaap	Temporary Equity Dividends Adjustment TemporaryEquityDividendsAdjustment	2039000	usd
CY2022Q2	mdxg	Temporary Equity Accretionof Increasingrate Dividend Feature TemporaryEquityAccretionofIncreasingrateDividendFeature	0	usd
CY2021Q2	mdxg	Temporary Equity Accretionof Increasingrate Dividend Feature TemporaryEquityAccretionofIncreasingrateDividendFeature	464000	usd
	mdxg	Temporary Equity Accretionof Increasingrate Dividend Feature TemporaryEquityAccretionofIncreasingrateDividendFeature	0	usd
	mdxg	Temporary Equity Accretionof Increasingrate Dividend Feature TemporaryEquityAccretionofIncreasingrateDividendFeature	926000	usd
CY2022Q2	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	1628000	usd
CY2021Q2	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	1497000	usd
	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	3214000	usd
	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	2965000	usd
CY2022Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-12496000	usd
CY2021Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-3276000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-24571000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-13126000	usd
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	112867912	shares
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	110276636	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	112245334	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	109841428	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	109841428	shares
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.11
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.22
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.12
CY2022Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-12496000	usd
CY2021Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-3276000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-24571000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-13126000	usd
CY2022Q2	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	1628000	usd
CY2021Q2	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	1497000	usd
	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	3214000	usd
	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	2965000	usd
CY2022Q2	us-gaap	Other Preferred Stock Dividends And Adjustments OtherPreferredStockDividendsAndAdjustments	-1628000	usd
CY2021Q2	us-gaap	Other Preferred Stock Dividends And Adjustments OtherPreferredStockDividendsAndAdjustments	-1497000	usd
	us-gaap	Other Preferred Stock Dividends And Adjustments OtherPreferredStockDividendsAndAdjustments	-3214000	usd
	us-gaap	Other Preferred Stock Dividends And Adjustments OtherPreferredStockDividendsAndAdjustments	-2965000	usd
CY2022Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-12496000	usd
CY2021Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-3276000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-24571000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-13126000	usd
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	112867912	shares
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	110276636	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	112245334	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	109841428	shares
CY2022Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	29199666	shares
CY2021Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	30373856	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	29102650	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	30232150	shares
CY2022Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	29199666	shares
CY2021Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	30373856	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	29102650	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	30232150	shares
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	112867912	shares
CY2021Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	110276636	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	112245334	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	109841428	shares
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.11
CY2021Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.03
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.22
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.12
CY2022Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	29199666	shares
CY2021Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	30373856	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	29102650	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	30232150	shares
CY2020Q3	mdxg	Temporary Equity Conversion Price Per Share TemporaryEquityConversionPricePerShare	5.25
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	5.99
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P1Y3M
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1444845	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	5.18
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	234334	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	1.86
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	0	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	0
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	56000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	2.27
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1154511	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	84791	usd
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	1154511	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	5.99
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P1Y3M
CY2022Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	84791	usd
CY2022Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.006
CY2021Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.003
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.006
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.005
	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	189000	usd
	mdxg	Notes Receivable For Sale Of Property And Equipment NotesReceivableForSaleOfPropertyAndEquipment	0	usd
	us-gaap	Interest Paid Net InterestPaidNet	2080000	usd
	us-gaap	Interest Paid Net InterestPaidNet	2207000	usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid	184000	usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid	157000	usd
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	255000	usd
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	67000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	37000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	usd
	mdxg	Temporary Equity Deemed Dividends TemporaryEquityDeemedDividends	0	usd
	mdxg	Temporary Equity Deemed Dividends TemporaryEquityDeemedDividends	926000	usd
	mdxg	Fair Value Of Non Cash Consideration Received For Option Exercise FairValueOfNonCashConsiderationReceivedForOptionExercise	0	usd
	mdxg	Fair Value Of Non Cash Consideration Received For Option Exercise FairValueOfNonCashConsiderationReceivedForOptionExercise	380000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	0	usd
	mdxg	Notes Receivable For Sale Of Property And Equipment NotesReceivableForSaleOfPropertyAndEquipment	75000	usd
CY2022Q2	us-gaap	Contractual Obligation ContractualObligation	13300000	usd
CY2022Q2	mdxg	Contractual Obligation To Be Paid Next Thirty Days ContractualObligationToBePaidNextThirtyDays	2000000	usd
CY2022Q2	mdxg	Contractual Commitment Payment Period ContractualCommitmentPaymentPeriod	P30D
CY2022Q2	mdxg	Contractual Commitment Termination Period ContractualCommitmentTerminationPeriod	P30D
CY2022Q2	us-gaap	Loss Contingency Accrual At Carrying Value LossContingencyAccrualAtCarryingValue	0	usd
	us-gaap	Payments For Legal Settlements PaymentsForLegalSettlements	700000	usd
CY2019Q1	mdxg	Contingency Loss Number Of Securities Class Actions ContingencyLossNumberOfSecuritiesClassActions	2	classaction
CY2022Q2	mdxg	Number Of Products NumberOfProducts	2	product
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	66883000	usd
CY2021Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	68165000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	125777000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	128132000	usd
CY2022Q2	mdxg	Revenue From Contract With Customer Number Of Distribution Channels RevenueFromContractWithCustomerNumberOfDistributionChannels	2	distributionchannel
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	66883000	usd
CY2021Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	68165000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	125777000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	128132000	usd

Files In Submission

Name	View Source	Status
0001376339-22-000099-index-headers.html	Edgar Link	pending
0001376339-22-000099-index.html	Edgar Link	pending
0001376339-22-000099.txt	Edgar Link	pending
0001376339-22-000099-xbrl.zip	Edgar Link	pending
a20220630-10qexhibit311.htm	Edgar Link	pending
a20220630-10qexhibit312.htm	Edgar Link	pending
a20220630-10qexhibit321.htm	Edgar Link	pending
a20220630-10qexhibit322.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
mdxg-20220630.htm	Edgar Link	pending
mdxg-20220630.xsd	Edgar Link	pending
mdxg-20220630_cal.xml	Edgar Link	unprocessable
mdxg-20220630_def.xml	Edgar Link	unprocessable
mdxg-20220630_htm.xml	Edgar Link	completed
mdxg-20220630_lab.xml	Edgar Link	unprocessable
mdxg-20220630_pre.xml	Edgar Link	unprocessable
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MDXG
MIMEDX GROUP, INC. Stock $mdxg

2022 Q3 Form 10-Q Financial Statement

#000137633922000099 Filed on August 02, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MDXG MIMEDX GROUP, INC. Stock $mdxg

2022 Q3 Form 10-Q Financial Statement

#000137633922000099 Filed on August 02, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MDXG
MIMEDX GROUP, INC. Stock $mdxg